Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study
The aim of this study was to evaluate the prognostic impact of FLT3-ITD in core-binding factor acute myeloid leukemia (CBFAML) in an international, multicenter survey of 97 patients of whom 52% had t(8;21)(q22;q22) and 48% had inv(16)(p13q22)/t(16;16)(p13;q22). The median age of the patients was 53...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 2022
|
| In: |
Haematologica
Year: 2022, Volume: 107, Issue: 4, Pages: 836-843 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2021.278645 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/haematol.2021.278645 Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/haematol.2021.278645 
|
| Author Notes: | Sabine Kayser, Michael Kramer, David Martínez-Cuadrón, Justin Grenet, Klaus H. Metzeler, Zuzana Sustkova, Marlise R. Luskin, Andrew M. Brunner, Michelle A. Elliott, Cristina Gil, Sandra Casal Marini, Zdeněk Ráčil, Petr Cetkovsky, Jan Novak, Alexander E. Perl, Uwe Platzbecker, Friedrich Stölzel, Anthony D. Ho, Christian Thiede, Richard M. Stone, Christoph Röllig, Pau Montesinos, Richard F. Schlenk and Mark J. Levis |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1815853034 | ||
| 003 | DE-627 | ||
| 005 | 20230118150408.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220906s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2021.278645 |2 doi | |
| 035 | |a (DE-627)1815853034 | ||
| 035 | |a (DE-599)KXP1815853034 | ||
| 035 | |a (OCoLC)1361696763 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kayser, Sabine |d 1979- |e VerfasserIn |0 (DE-588)138694923 |0 (DE-627)605256233 |0 (DE-576)30778813X |4 aut | |
| 245 | 1 | 0 | |a Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD |b results from an international collaborative study |c Sabine Kayser, Michael Kramer, David Martínez-Cuadrón, Justin Grenet, Klaus H. Metzeler, Zuzana Sustkova, Marlise R. Luskin, Andrew M. Brunner, Michelle A. Elliott, Cristina Gil, Sandra Casal Marini, Zdeněk Ráčil, Petr Cetkovsky, Jan Novak, Alexander E. Perl, Uwe Platzbecker, Friedrich Stölzel, Anthony D. Ho, Christian Thiede, Richard M. Stone, Christoph Röllig, Pau Montesinos, Richard F. Schlenk and Mark J. Levis |
| 264 | 1 | |c April 2022 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 2021-08-05 | ||
| 500 | |a Gesehen am 06.09.2022 | ||
| 520 | |a The aim of this study was to evaluate the prognostic impact of FLT3-ITD in core-binding factor acute myeloid leukemia (CBFAML) in an international, multicenter survey of 97 patients of whom 52% had t(8;21)(q22;q22) and 48% had inv(16)(p13q22)/t(16;16)(p13;q22). The median age of the patients was 53 years (range, 19-81). Complete remission after anthracycline-based induction (n=86) and non-intensive therapy (n=11) was achieved in 97% and 36% of the patients, respectively. The median follow-up was 4.43 years (95% confidence interval [95% CI]: 3.35-7.39 years). The median survival after intensive and non-intensive treatment was not reached and 0.96 years, respectively. Among intensively treated patients, inv(16) with trisomy 22 (n=11) was associated with a favorable 4-year relapse-free survival rate of 80% (95% CI: 59-100%) as compared to 38% (95% CI: 27-54%; P=0.02) in all other patients with CBFAML/ FLT3-ITD (n=75). Overall, 24 patients underwent allogeneic hematopoietic cell transplantation (HCT), 12 in first complete remission and 12 after relapse. Allogeneic HCT in first complete remission was not beneficial (P=0.60); however, allogeneic HCT seemed to improve median survival in relapsed patients compared to that of patients treated with chemotherapy (not reached vs. 0.6 years, respectively; P=0.002). Excluding patients with inv(16) with trisomy 22, our data indicate that compathe outcome of CBF-AML patients with FLT3-ITD may be inferior to that of patients without FLT3-ITD (based on previously published data), suggesting that prognostically CBF-AML patients with FLT3-ITD should not be classified as favorable-risk. FLT3-inhibitors may improve the outcome of these patients. | ||
| 700 | 1 | |a Kramer, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martínez-Cuadrón, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Grenet, Justin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Metzeler, Klaus H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sustkova, Zuzana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Luskin, Marlise R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brunner, Andrew M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Elliott, Michelle A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gil, Cristina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marini, Sandra Casal |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ráčil, Zdeněk |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cetkovsky, Petr |e VerfasserIn |4 aut | |
| 700 | 1 | |a Novak, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Perl, Alexander E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Platzbecker, Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stölzel, Friedrich |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Thiede, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stone, Richard M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Röllig, Christoph |d 1971- |e VerfasserIn |0 (DE-588)122493168 |0 (DE-627)705929116 |0 (DE-576)293296049 |4 aut | |
| 700 | 1 | |a Montesinos, Pau |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schlenk, Richard Friedrich |d 1965- |e VerfasserIn |0 (DE-588)129025380 |0 (DE-627)387778004 |0 (DE-576)297454102 |4 aut | |
| 700 | 1 | |a Levis, Mark J. |e VerfasserIn |0 (DE-588)1163573825 |0 (DE-627)1027896227 |0 (DE-576)508064465 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d Pavia : Ferrata Storti Foundation, 2014 |g 107(2022), 4, Seite 836-843 |h Online-Ressource |w (DE-627)814204899 |w (DE-600)2805244-4 |w (DE-576)424051125 |x 1592-8721 |7 nnas |a Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD results from an international collaborative study |
| 773 | 1 | 8 | |g volume:107 |g year:2022 |g number:4 |g pages:836-843 |g extent:8 |a Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD results from an international collaborative study |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2021.278645 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://haematologica.org/article/view/haematol.2021.278645 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220906 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 129025380 |a Schlenk, Richard Friedrich |m 129025380:Schlenk, Richard Friedrich |d 910000 |d 910100 |e 910000PS129025380 |e 910100PS129025380 |k 0/910000/ |k 1/910000/910100/ |p 23 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 18 | ||
| 998 | |g 138694923 |a Kayser, Sabine |m 138694923:Kayser, Sabine |d 60000 |d 63500 |e 60000PK138694923 |e 63500PK138694923 |k 0/60000/ |k 1/60000/63500/ |p 1 |x j | ||
| 999 | |a KXP-PPN1815853034 |e 418496222X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"subtitle":"results from an international collaborative study","title":"Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD","title_sort":"Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD"}],"language":["eng"],"id":{"eki":["1815853034"],"doi":["10.3324/haematol.2021.278645"]},"physDesc":[{"extent":"8 S."}],"note":["Published: 2021-08-05","Gesehen am 06.09.2022"],"relHost":[{"title":[{"title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title_sort":"Haematologica"}],"language":["eng"],"part":{"pages":"836-843","extent":"8","issue":"4","text":"107(2022), 4, Seite 836-843","year":"2022","volume":"107"},"pubHistory":["99.2014 -"],"disp":"Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD results from an international collaborative studyHaematologica","id":{"issn":["1592-8721"],"zdb":["2805244-4"],"eki":["814204899"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 27.05.2022"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Pavia","publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2014-","dateIssuedKey":"2014"}],"recId":"814204899"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1815853034","origin":[{"dateIssuedDisp":"April 2022","dateIssuedKey":"2022"}],"person":[{"family":"Kayser","given":"Sabine","role":"aut","display":"Kayser, Sabine"},{"role":"aut","given":"Michael","display":"Kramer, Michael","family":"Kramer"},{"role":"aut","given":"David","display":"Martínez-Cuadrón, David","family":"Martínez-Cuadrón"},{"family":"Grenet","role":"aut","given":"Justin","display":"Grenet, Justin"},{"role":"aut","given":"Klaus H.","display":"Metzeler, Klaus H.","family":"Metzeler"},{"display":"Sustkova, Zuzana","role":"aut","given":"Zuzana","family":"Sustkova"},{"role":"aut","given":"Marlise R.","display":"Luskin, Marlise R.","family":"Luskin"},{"family":"Brunner","display":"Brunner, Andrew M.","given":"Andrew M.","role":"aut"},{"display":"Elliott, Michelle A.","role":"aut","given":"Michelle A.","family":"Elliott"},{"family":"Gil","display":"Gil, Cristina","role":"aut","given":"Cristina"},{"display":"Marini, Sandra Casal","given":"Sandra Casal","role":"aut","family":"Marini"},{"family":"Ráčil","role":"aut","given":"Zdeněk","display":"Ráčil, Zdeněk"},{"display":"Cetkovsky, Petr","role":"aut","given":"Petr","family":"Cetkovsky"},{"display":"Novak, Jan","role":"aut","given":"Jan","family":"Novak"},{"family":"Perl","given":"Alexander E.","role":"aut","display":"Perl, Alexander E."},{"role":"aut","given":"Uwe","display":"Platzbecker, Uwe","family":"Platzbecker"},{"family":"Stölzel","display":"Stölzel, Friedrich","role":"aut","given":"Friedrich"},{"family":"Ho","display":"Ho, Anthony Dick","role":"aut","given":"Anthony Dick"},{"given":"Christian","role":"aut","display":"Thiede, Christian","family":"Thiede"},{"family":"Stone","given":"Richard M.","role":"aut","display":"Stone, Richard M."},{"display":"Röllig, Christoph","role":"aut","given":"Christoph","family":"Röllig"},{"family":"Montesinos","role":"aut","given":"Pau","display":"Montesinos, Pau"},{"family":"Schlenk","display":"Schlenk, Richard Friedrich","role":"aut","given":"Richard Friedrich"},{"role":"aut","given":"Mark J.","display":"Levis, Mark J.","family":"Levis"}],"name":{"displayForm":["Sabine Kayser, Michael Kramer, David Martínez-Cuadrón, Justin Grenet, Klaus H. Metzeler, Zuzana Sustkova, Marlise R. Luskin, Andrew M. Brunner, Michelle A. Elliott, Cristina Gil, Sandra Casal Marini, Zdeněk Ráčil, Petr Cetkovsky, Jan Novak, Alexander E. Perl, Uwe Platzbecker, Friedrich Stölzel, Anthony D. Ho, Christian Thiede, Richard M. Stone, Christoph Röllig, Pau Montesinos, Richard F. Schlenk and Mark J. Levis"]}} | ||
| SRT | |a KAYSERSABICHARACTERI2022 | ||